Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.Euro Surveill. 2013 Feb 14; 18(7):2.ES
Abstract
We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenzalike illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.
Links
MeSH
AdolescentAdultAgedCase-Control StudiesChildChild, PreschoolFemaleHospitalizationHumansIncidenceInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza A Virus, H3N8 SubtypeInfluenza B virusInfluenza VaccinesInfluenza, HumanLogistic ModelsMaleMiddle AgedPopulation SurveillanceProspective StudiesSeasonsSpainTreatment OutcomeVaccinationYoung Adult
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
23449182
Citation
Castilla, J, et al. "Early Estimates of Influenza Vaccine Effectiveness in Navarre, Spain: 2012/13 Mid-season Analysis." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 18, no. 7, 2013, p. 2.
Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill. 2013;18(7):2.
Castilla, J., Martinez-Baz, I., Martinez-Artola, V., Fernandez-Alonso, M., Reina, G., Guevara, M., Garcia Cenoz, M., Elia, F., Alvarez, N., Barricarte, A., & Ezpeleta, C. (2013). Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 18(7), 2.
Castilla J, et al. Early Estimates of Influenza Vaccine Effectiveness in Navarre, Spain: 2012/13 Mid-season Analysis. Euro Surveill. 2013 Feb 14;18(7):2. PubMed PMID: 23449182.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
AU - Castilla,J,
AU - Martinez-Baz,I,
AU - Martinez-Artola,V,
AU - Fernandez-Alonso,M,
AU - Reina,G,
AU - Guevara,M,
AU - Garcia Cenoz,M,
AU - Elia,F,
AU - Alvarez,N,
AU - Barricarte,A,
AU - Ezpeleta,C,
Y1 - 2013/02/14/
PY - 2013/3/2/entrez
PY - 2013/3/2/pubmed
PY - 2013/4/25/medline
SP - 2
EP - 2
JF - Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
JO - Euro Surveill
VL - 18
IS - 7
N2 - We present estimates of influenza vaccine effectiveness (VE) in Navarre, Spain, in the early 2012/13 season, which was dominated by influenza B. In a population-based cohort using electronic records from physicians, the adjusted VE in preventing influenzalike illness was 32% (95% confidence interval (CI): 15 to 46). In a nested test-negative case-control analysis the adjusted VE in preventing laboratory-confirmed influenza was 86% (95% CI: 45 to 96). These results suggest a high protective effect of the vaccine.
SN - 1560-7917
UR - https://www.unboundmedicine.com/medline/citation/23449182/Early_estimates_of_influenza_vaccine_effectiveness_in_Navarre_Spain:_2012/13_mid_season_analysis_
L2 - http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20404
DB - PRIME
DP - Unbound Medicine
ER -